published meta-analysis   sensitivity analysis   studies

control in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsGLUCOCOVID, 2020 0.63 [0.25; 1.60] REMAP-CAP, shock-dependent course, 2020 1.10 [0.58; 2.10] 0.92[0.54; 1.56]GLUCOCOVID, 2020, REMAP-CAP, shock-dependent course, 202020%304seriousnot evaluable death or transfer to ICUdetailed resultsGLUCOCOVID, 2020 (REV) 1.47 [0.80; 2.71] 1.47[0.80; 2.71]GLUCOCOVID, 2020 (REV)10%63NAnot evaluable deathsdetailed resultsGLUCOCOVID, 2020 0.63 [0.25; 1.60] REMAP-CAP, shock-dependent course, 2020 0.98 [0.63; 1.53] 0.90[0.60; 1.35]GLUCOCOVID, 2020, REMAP-CAP, shock-dependent course, 202020%324seriousnot evaluable deaths (time to event analysis only)detailed resultsREMAP-CAP, shock-dependent course, 2020 0.98 [0.63; 1.53] 0.98[0.63; 1.53]REMAP-CAP, shock-dependent course, 202010%260NAnot evaluable clinical improvementdetailed resultsREMAP-CAP, shock-dependent course, 2020 1.22 [0.76; 1.95] 1.22[0.76; 1.95]REMAP-CAP, shock-dependent course, 202010%260NAnot evaluable clinical improvement (14-day)detailed resultsREMAP-CAP, shock-dependent course, 2020 1.03 [0.65; 1.64] 1.03[0.65; 1.64]REMAP-CAP, shock-dependent course, 202010%260NAnot evaluable death or ventilationdetailed resultsREMAP-CAP, shock-dependent course, 2020 1.24 [0.55; 2.78] 1.24[0.55; 2.78]REMAP-CAP, shock-dependent course, 202010%118NAnot evaluable ICU admissiondetailed resultsGLUCOCOVID, 2020 0.85 [0.27; 2.67] 0.85[0.27; 2.67]GLUCOCOVID, 202010%64NAnot evaluable serious adverse eventsdetailed resultsREMAP-CAP, shock-dependent course, 2020 3.68 [0.42; 31.96] 3.68[0.42; 31.96]REMAP-CAP, shock-dependent course, 202010%242NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-06-14 23:56 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 649,650,589,651,968 - roots T: 290